VOLC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GuruFocus Financial Strength Rank measures how strong a companys financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank
|Manning & Napier Advisors, Inc 4,733,937 sh (+19.59%)||Steven Cohen 426,000 sh (unchged)|
|Jim Simons 408,766 sh (New)|
Paul Tudor Jones 15,981 sh (New)
Manning & Napier Advisors, Inc 5,961,507 sh (+25.93%)
|Steven Cohen Sold Out|
|Mario Gabelli 572,500 sh (New)||Manning & Napier Advisors, Inc Sold Out|
Paul Tudor Jones Sold Out
Jim Simons 363,400 sh (-11.10%)
(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
|Industry:||Medical Devices » Medical Devices|
|Compare:||SZSE:300216, SZSE:000607, NAS:BABY, TSE:3360, SZSE:002317, SZSE:300326 » details|
|Traded in other countries:||VQY.Germany,|
Volcano Corp incorporated in the state of Delaware in January 2000. The Company completed its initial public offering on June 15, 2006. The Company designs, develops, manufactures and commercializes a broad suite of precision guided therapy tools including intravascular ultrasound, or IVUS, and fractional flow reserve, or FFR, products. The IVUS products include single-procedure disposable phased array and rotational IVUS imaging catheters, and additional functionality options such as ChromaFlo stent apposition analysis. FFR offerings can be accessed through its multi-modality platforms, and it also provide FFR-only consoles. Its products include: IVUS Products, Catheters, its single-use disposable catheters operate and interface solely with its family of consoles. Catheters, its single-use disposable catheters operate and interface solely with its family of consoles. ChromaFlo stent apposition analysis technology uses sequential IVUS frames to differentiate circulating blood from stationary or anchored tissue. SyncVision, Sync-Rx Ltd, or Sync-Rx, an Israel-based company that develops advanced software applications designed to optimize and facilitate trans-catheter cardiovascular interventions using automated online image processing. FFR products consist of pressure and flow consoles and single-procedure disposable pressure and flow guide wires. The Company's primary imaging competitors globally are Boston Scientific, Inc., or Boston Scientific, with its IVUS offering and St. Jude Medical, Inc., or St. Jude with its OCT offering. In Japan, it also competes with Terumo Corporation, which offers both IVUS and OCT. In the FFR market, its primary competitor is St. Jude. Because of the size of the vascular market opportunities, competitors and potential competitors have dedicated and will continue to dedicate significant resources to aggressively promote their products. It has registered and common law trademarks in the U.S. and elsewhere in the world including, but not limited to, Aim, Axsun, Bi-Trieval, Centriq, ChromaFlo, ComboMap, ComboWire, Core, Crux, Crux Biomedical, Define, Eagle Eye, ETNA, FACT, FloMap, FloWire, Ginko, GlyDx, Hi-Q, iFR, In-Line Digital, Instant Wave-Free Ratio, Intentio, Octave, pcFM, Precision Guided Therapy, PreView, PrimeWire, PrimeWire Prestige, ReFlow, Revolution, SlyDx, s5i, SmartMap, SpinVision, Sync-Rx, Trak Back, Valet, Verrata, VH, VIBE, Virtual Histology, Visions, Volcano, Wavewire, Xtract and Zuum. The Company's medical device products are subject to extensive and rigorous regulation by the FDA, as well as other federal and state regulatory bodies in the U.S. and comparable authorities in other countries.
|Revenue (TTM) (Mil) $||397.9|
|EPS (TTM) $||-0.74|
|Short Percentage of Float||11.16%|
|52-Week Range $||9.81 - 24.62|
|Shares Outstanding (Mil)||51.60|
|Revenue (Mil $)||395||403|
|EPS without NRI ($)||-0.38||-0.00||0.28|
|EPS Growth Rate |
(3Y to 5Y Estimate)
|Mario Gabelli's Top 5 Stock Picks Mar 30 2015|
|Mario Gabelli's Top 5 New Stock Buys of Q4 Feb 05 2015|
|Gabelli's Q4 Picks Include Acquisition Targets Feb 06 2015|
|Gabelli Raises Stakes in Three Companies in First Two Weeks of New Year Jan 20 2015|
|5-year lows: Hecla Mining Co, Comstock Resources Inc, Permian Basin Royalty Trust, and Volcano Corp. Nov 02 2014|
|Weekly 3-Year Low Highlights: CHT, NE, HL, VOLC Sep 21 2014|
|Who Is Mariko Gordon? A Guru to Follow Aug 30 2013|
|Weekly Guru Bargains Highlights: GOLD, GFI, SAPMY, APPL, VOLC May 20 2013|
|Weekly Guru Bargains Highlights: VOLC, SAPMY, BVN, NEM, TFM May 13 2013|
|Weekly Guru Bargains Highlights: GOLD, NEM, ABX, VOLC, GFI May 06 2013|